FREXALIMAB
UNII WO7SFK0ENJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Frexalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WO7SFK0ENJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2515463-86-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WO7SFK0ENJ

CAS Registry Number

2515463-86-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FREXALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190493

National Cancer Institute reference terminology for clinical and research data.

INN ID

11963

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-99

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Frexalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FREXALIMAB

Common Names & Synonyms

FREXALIMAB [INN]

FREXALIMAB [USAN]

FREXALIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (272-ARGININE,325-ALANINE), ANTI-(HUMAN CD40 LIGAND) (HUMAN-MUS MUSCULUS MONOCLONAL SAR441344 GAMMA1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SAR441344 KAPPA-CHAIN, DIMER